Evaluation of a new semi-automated high-performance liquid chromatography method for glycosylated haemoglobins

The authors report data on the evaluation of a new ion-exchange high performance liquid chromatographic system (HLC-723GHb Glycopack-Dyamat), recently introduced by Bio-Rad Laboratories (Segrate, Milano, Italy) to measure the glycosylated haemoglobins in blood samples. The system operates on haemolysates, which have to be performed separately, by diluting 5 \u3bcl of blood with 1 ml of haemolysing reagent. Each analysis takes about 8 min and the results are printed-out, together with a chromatogram. Precision and accuracy (comparison with the minicolumn ion-exchange method) were found to be excellent. The analysis if not affected by the presence of the so-called 'labile fractions', as demonstrated by experiments of incubation with glucose or saline solutions at 37\ub0 C. Some haemolysates containing abnormal haemoglobins (HbS, HbE, HbJ Paris and Hb Lepore) were also analysed. The effects of the different mutants on the glycated haemoglobins assay are discussed. The HbF content is also measured by this system, but the accuracy, concerning this particular determination, at the lower concentrations (HbF <2%) is not satisfactory, and needs further improvement

Misidentification and Other Preanalytical Errors

Misidentification and Other Preanalytical Errors The largest number of laboratory errors occur in the preanalytical phase and are mainly due to educational and organizational reasons. The experience of our institution, as well as the results of an Italian interlaboratory effort to detect and reduce errors/risk of errors in laboratory medicine will be illustrated

Evaluation of the Coulter Counter S-Plus VI

This article reports an evaluation of the Coulter Counter model S-Plus VI automatic analyser for haematology, and data are presented on linearity, carry-over, precision, accuracy and stability of the instrument, when compared with a model S-Plus IV/D

Automation in urinalysis: evaluation of three urine test strip analysers

A clinical laboratory evaluation was conducted on the Clinitek Auto 2000, the Super Aution Analyzer and the Urotron RL9 for the determination of glucose, protein, pH, blood, ketone-bodies and bilirubin

Multicentre evaluation of the Monarch (IL) clinical chemistry analyser

A multicentre evaluation of the Monarch centrifugal analyser is reported. Precision, linearity and accuracy were assessed by comparison with routine methods. Calibration stability, photometric and dispensing accuracy, and carry-over related to samples and reagents were also evaluated. The overall performance of the instrument was good, showing an excellent photometric and dispensing accuracy, absence of sample-dependent carry-over, and almost negligible reagent carry-over. Good precision, linearity and correlation with routine methods were found for the parameters tested. The instrument is reliable and is now used as the routine clinical chemistry analyser in two of the three laboratories taking part in the evaluation

Multicentre evaluation of the Boehringer Mannheim/Hitachi 917 analysis system

The new selective access analysis system BM/Hitachi 917 was evaluated in an international multicentre study, mainly according to the ECCLS protocol for the evaluation of analysers in clinical chemistry. Forty-three different analytes, covering 56 different methods enzymes, substrates, electrolytes, specific proteins, drugs and urine applications were tested in seven European clinical chemistry laboratories. Additionally, the practicability of the BM/ Hitachi 917 was tested according to a standardized questionnaire. Within-run CVs (median of 3 days) for enzymes, substrates and electrolytes were <2% except for creatine-kinase MB isoform and lipase at low concentration. For proteins, drugs and urine analytes the within-run CVs were < 4% except for digoxin and albumin in urine. Between-day median CVs were generally < 3% for enzymes, substrates and electrolytes, and < 6% for proteins, drugs and urine analytes, except for lipase, creatine kinase and MB isoform, D-dimer, glycosylated haemoglobin, rheumatoid factors, digoxin, digitoxin, theophylline and albumin in urine in some materials. Linearity was found according to the test specifications or better and there were no relevant effects seen in drift and carry-over testing. The interference results clearly show that also for the BM/Hitachi 917 interference exists sometimes, as could be expected because of the chemistries applied. It is a situation that can be found in equivalent analysers as well. The accuracy is acceptable regarding a 95–105% recovery in standard reference material, with the exception of the creatinine Jaffé method. Most of the 160 method comparisons showed acceptable agreement according to our criteria: enzymes, substrates, urine analytes deviation of slope ± 5%, electrolytes ± 3%, and proteins and drugs ± 10%. The assessment of practicability for 14 groups of attributes resulted in a grading of one–three scores better for the BM/Hitachi 917 than the present laboratory situation. In conclusion, the results of the study showed good analytical performance and confirmed the usefulness of the system as a consolidated workstation in medium-sized to large clinical chemistry laboratories